MTN-004

A study that evaluated the safety, acceptability and ease of use of the microbicide candidate VivaGel^® in sexually active, HIV-negative women ages 18 to 24.

See

Phase I Study Finds Candidate Microbicide VivaGel Generally Well Tolerated but Women Less Willing to Use It [1]

May 25, 2010

Safety of new microbicide for HIV prevention to be tested in young women in U.S. tria [2]l

Jul 9, 2007

MTN-004 Backgrounder [3]

MTN-004 Q&A [4]

See Also

MTN-004 Study Protocol [5]

Links:
[1] http://www.mtnstopshiv.org/node/1847
[2] http://www.mtnstopshiv.org/node/343
[3] http://www.mtnstopshiv.org/news/studies/mtn004/backgrounder
[4] http://www.mtnstopshiv.org/news/studies/mtn004/qa
[5] http://www.mtnstopshiv.org/sites/default/files/attachments/MTN%20004%20Version%203%200_30JUNE08.pdf
[6] http://www.mtnstopshiv.org/print/824

Media Contacts:

Lisa Rossi -- Office: +1 412 641-8940 -- Mobile: +1 412 916-3315 -- Email: rossil@upmc.edu

Clare Collins -- Office: +1 412 641-7299 -- Mobile: +1 412 770-8643 -- Email: collcx@upmc.edu